The FDA approved 19 biosimilars in 2024, a sharp jump from the five greenlit by the agency in 2023. 2024 saw the highest ...

AGC Biologics has collaborated with Quell Therapeutics to advance the development of several T-regulatory (Treg) cell therapy ...

Artificial Intelligence (AI) is now used throughout clinical trials, from recruitment to analysis – but are regulators ...

Pathos AI has raised $365m in a Series D funding round to widen its AI-enabled platform to advance the development of ...

From predictive analytics to robotic warehousing, automation is unlocking new efficiencies in pharma logistics.

The FDA has approved MSD’s Welireg for rare adrenal tumours, and AbbVie’s Emrelis for treating c-Met+ lung cancer patients.

Pharmaceutical Technology Excellence Awards are now open for submissions, and you can download our Research Guide for more ...

The US Food and Drug Administration (FDA) has accepted BioCryst Pharmaceuticals’ new drug application (NDA) for Orladeyo.

As pressure to comply with stringent environmental regulations mounts, could green chemistry strategies provide the solution?

AbbVie has signed a collaboration and licensing agreement with US-based ADARx Pharmaceuticals, committing $335m upfront to ...

Boehringer Ingelheim has entered a multi-year partnership with Tempus AI to progress its cancer treatment pipeline.

The French drugmaker said it would commit at least $20bn in the US through 2030, with the aim to increase R&D and ...